Rigel Pharmaceuticals | RIGL - Market Capitalization


Rigel Pharmaceuticals reported $7.35B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 3.19B 3.06B Aug/2026
Amgen USD 209.65B 14.21B Aug/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 10.84B 664M Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
BioMarin Pharmaceutical USD 11.71B 651M Aug/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Celldex Therapeutics USD 2.76B 161M Aug/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
Halozyme Therapeutics USD 10.91B 1.63B Aug/2026
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
Ligand Pharmaceuticals USD 5.31B 1.02B Aug/2026
MacroGenics USD 184M 82M Mar/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Pfizer USD 153.17B 14.73B Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Ultragenyx Pharmaceutical USD 2.12B 1.16B Aug/2026
Veracyte USD 4.69B 2.12B Jun/2026